Huro Probiotics participates in UK research of COVID-19 medication

00:12 10/12/2020

Destiny Pharma and SporeGen entered into a collaboration agreement in the research and development of SPOR-COV, a preventive treatment for COVID-19. The manufacturing and formulation development work...

View More >>